Yini i-Ipilimumab: Ukusetshenziswa, Umthamo, Imiphumela Eceleni nokuningi

I-Ipilimumab iyimithi enamandla yokwelapha umdlavuza nge-immunotherapy esiza amasosha akho omzimba ukuthi alwe nezinhlobo ezithile zomdlavuza ngempumelelo enkulu. Inikezwa nge-IV esibhedlela noma emtholampilo, futhi isebenza ngokususa amabhuleki emasosheni akho omzimba ukuze akwazi ukubona kangcono futhi ahlaselwe amaseli omdlavuza.

Le mithi imelela intuthuko enkulu ekwelapheni umdlavuza, inikeza ithemba ezigulini ezinama-melanoma athuthukile kanye neminye imidlavuza emibi. Ngenkathi ingabangela imiphumela emibi ebalulekile, iziguli eziningi ziye zaba nokuthuthuka okumangalisayo emiphumeleni yazo yomdlavuza ngale ndlela yokwelapha.

Yini i-Ipilimumab?

I-Ipilimumab wuhlobo lwe-immunotherapy olubizwa ngokuthi i-checkpoint inhibitor. Kuyi-antibody eyenziwe e-laboratory eqondiswe kuphrotheni ebizwa nge-CTLA-4 ezingxenyeni zakho zamasosha omzimba.

Cabanga nge-CTLA-4 njenge-pedal yamabhuleki emasosheni akho omzimba. Amaseli omdlavuza avame ukukhohlisa umzimba wakho ukuthi ugcine la mabhuleki evuliwe, okuvimbela amasosha akho omzimba ukuthi alwe nomdlavuza ngempumelelo. I-Ipilimumab ivimba leli bhuleki, ivumela amasosha akho omzimba ukuthi asebenze kanzima ngokumelene nomdlavuza.

Le mithi ingeyeqembu lezidakamizwa ezibizwa ngokuthi ama-monoclonal antibodies. Yenzelwe ngokuqondile ukulingisa nokuthuthukisa impendulo yakho yemvelo yomzimba, kodwa ngendlela eqondiwe futhi enamandla.

Isetshenziselwani i-Ipilimumab?

I-Ipilimumab isetshenziswa ikakhulukazi ukwelapha i-melanoma ethuthukile, uhlobo olubi kakhulu lomdlavuza wesikhumba. Ivunyelwe futhi ukwelapha izinhlobo ezithile zomdlavuza wamaphaphu, umdlavuza wezinso, kanye nomdlavuza wesibindi ezimweni ezithile.

Udokotela wakho angase ancome i-ipilimumab uma umdlavuza wakho usabalale kwezinye izingxenye zomzimba wakho noma uma ezinye izindlela zokwelapha zingasebenzi. Ivame ukusetshenziswa lapho ukuhlinzwa kungenzeki noma ngemva kokuhlinzwa ukusiza ukuvimbela umdlavuza ukuthi ubuye.

Kwesinye isikhathi, i-ipilimumab ihlanganiswa neminye imithi yokwelapha ngomzimba njenge-nivolumab ukuze kwakhiwe indlela yokwelapha enamandla. Udokotela wakho we-oncologist uzoqoka uhlelo olungcono kakhulu lokwelapha olusekelwe ohlotsheni lwakho oluthile lomdlavuza, isigaba sawo, nempilo yakho yonke.

Isebenza Kanjani I-Ipilimumab?

I-Ipilimumab isebenza ngokuvimba iphrothini yokuhlola ebizwa nge-CTLA-4 evame ukugcina amasosha akho omzimba elawulwa. Lokhu kuthathwa njengendlela enamandla futhi enamandla yokwelapha umdlavuza.

Lapho umdlavuza uvela, uvame ukuthola izindlela zokucasha kumasosha akho omzimba noma ukuvala amandla omzimba wakho emvelo okulwa nomdlavuza. I-CTLA-4 ingenye yezindlela umdlavuza ozisebenzisayo ukucindezela impendulo yakho yomzimba.

Ngokuvimba i-CTLA-4, i-ipilimumab empeleni ikhipha izihluthulelo zokuphepha kumasosha akho omzimba. Lokhu kuvumela ama-T-cells akho, okuyizinhlobo ezikhethekile zamasosha omzimba, ukuthi asebenze kakhulu futhi abe nolaka ekuhlaseleni amaseli omdlavuza emzimbeni wakho wonke.

Umuthi awabulali ngokuqondile amaseli omdlavuza njengoba kwenza i-chemotherapy yendabuko. Kunalokho, unika amandla amasosha akho omzimba ukuthi enze umsebenzi onzima, yingakho ibizwa ngokuthi i-immunotherapy.

Kufanele Ngiyithathe Kanjani I-Ipilimumab?

I-Ipilimumab ngaso sonke isikhathi inikezwa njenge-infusion ye-intravenous esibhedlela noma esikhungweni esikhethekile sokwelapha umdlavuza. Awukwazi ukuthatha lo muthi ekhaya, futhi idinga ukugadwa ngokucophelela kwezokwelapha.

I-infusion ngokuvamile ithatha imizuzu engaba ngu-90, futhi uzoyithola njalo ngemva kwamasonto ama-3 isamba semithamo emi-4. Ithimba lakho lezempilo lizokuqapha eduze ngesikhathi nangemva kwe-infusion ngayinye nganoma yiziphi izindlela eziphendulayo ngokushesha.

Ngaphambi kokwelashwa ngakunye, unganikezwa imithi yokusiza ukuvimbela ukusabela okungalungile. Akudingeki ukuthi uzile ukudla ngaphambi kwe-infusion, kodwa ukudla ukudla okulula ngaphambi kwesikhathi kungakusiza ukuthi uzizwe ukhululekile ngesikhathi sokwelashwa.

Iqembu lakho lezokwelapha lizohlola umsebenzi wegazi lakho njalo ukuze liqaphele ukuthi umzimba wakho usabela kanjani emithini nokubheka noma yimaphi imiphumela engathandeki. Kubalulekile ukugcina zonke izikhathi zakho ezihleliwe, ngisho noma uzizwa kahle.

Kufanele Ngiyithathe Isikhathi Esingakanani Ipilimumab?

Inkambo yokwelashwa ejwayelekile ye-ipilimumab yizilinganiso ezine ezinikezwa ngaphezu kwamasonto angu-12. Lokhu kwehluke ekwelashweni okuningi komdlavuza okuqhubeka izinyanga noma iminyaka.

Ngemuva kokuqeda izilinganiso zokuqala ezine, ngokuvamile ngeke uthole okunye i-ipilimumab ngaphandle uma umdlavuza wakho uqhubeka futhi udokotela wakho enquma ukuthi ukwelashwa okwengeziwe kungase kube usizo. Umuthi ungaqhubeka usebenza ohlelweni lwakho izinyanga noma iminyaka ngemuva komthamo wakho wokugcina.

Udokotela wakho we-oncologist uzoqapha intuthuko yakho ngokuskena njalo nokuhlolwa kwegazi ukuze abone ukuthi ukwelashwa kusebenza kahle kangakanani. Ezinye iziguli zibona ngcono phakathi nezinyanga ezimbalwa, kanti ezinye zingase zingaboni izinzuzo ezigcwele kuze kube izinyanga eziningana ngemuva kokuqeda ukwelashwa.

Uma uthola i-ipilimumab ngokuhlangana neminye imithi ye-immunotherapy, uhlelo lwakho lokwelashwa lungase luhluke. Udokotela wakho uzochaza uhlelo lwakho lokwelashwa oluthile kanye nomugqa wesikhathi.

Yiziphi Imiphumela Eceleni ye-Ipilimumab?

I-Ipilimumab ingabangela imiphumela emibi ebalulekile ngoba yenza ngcono amasosha akho omzimba, okungase ngezinye izikhathi kuhlasele izicubu ezinempilo kanye namaseli omdlavuza. Iziguli eziningi zithola eminye imiphumela emibi, kodwa ngokuvamile zilawuleka ngokunakekelwa kwezokwelapha okufanele.

Imiphumela emibi evame kakhulu ongase uyithole ihlanganisa ukukhathala, isifo sohudo, ukuqubuka kwesikhumba, nokucasuka. Lezi zimpawu zingahluka kusuka kokulula kuya kokukhulu futhi zingase zidinge ukwelashwa ngama-steroid noma eminye imithi.

Nawa amanye imiphumela emibi evame kakhulu ethinta iziguli eziningi:

• Ukukhathala nobuthakathaka obungahlala amasonto
• Ukuqunjelwa okungaba kubi futhi okungase kube negazi
• Ukuqubuka kwesikhumba, ukuluma, noma ukumnyama kwesikhumba
• Isicanucanu nokuncipha kwesifiso sokudla
• Ubuhlungu besisu nokubamba
• Ikhanda elibuhlungu nobuhlungu bemisipha

Lezi zimpawu ziyizimpawu zokuthi amasosha akho omzimba aya ngokuya esebenza, okuyilokho esikufunayo ukuthi kwenzeke ukuze ukwelashwa kusebenze ngempumelelo.

Imiphumela emibi engathi sína ingenzeka lapho amasosha akho omzimba asebenzayo ehlasela izitho ezinempilo. Le miphumela emibi ehlobene nokuzivikela emzimbeni ingaba mibi kodwa ngokuvamile iyabuyiseka ngemithi esheshayo.

Nansi imiphumela emibi engathi sína edinga ukunakekelwa kwezempilo ngokushesha:

• Ukuqunjelwa okukhulu noma i-colitis ethinta amathumbu akho
• Ukuvuvukala kwesibindi okungabangela ukuphuzi kwesikhumba noma amehlo
• Ukuvuvukala kwamaphaphu okubangela ubunzima bokuphefumula noma ukukhwehlela okuqhubekayo
• Izinkinga ze-gland ye-hormone ezithinta i-thyroid, i-pituitary, noma ama-adrenal glands akho
• Ukuphendula kwesikhumba okukhulu okuhlanganisa ukuqina noma ukuxebuka
• Izinkinga zesimiso sezinzwa ezibangela ukudideka noma izinguquko zombono

Ngenkathi le miphumela emibi engathi sína izwakala ikhathaza, ithimba lakho lezokwelapha liqeqeshwe kahle ukuyibona nokuyelapha ngokushesha. Iningi leziguli ezithola imiphumela emibi engathi sína zithola ukwelulama ngokuphelele ngemithi efanele.

Imiphumela emibi engavamile kodwa engathi sína ihlanganisa ukusabela okukhulu komzimba ngesikhathi sokufakwa, izinkinga zenhliziyo, nokuvuvukala kwezinso. Ithimba lakho lezempilo lizokuqapha eduze ngazo zonke lezi zinto ezingenzeka.

Ubani Ongafanele Athole i-Ipilimumab?

I-Ipilimumab ayifanele wonke umuntu, futhi udokotela wakho uzohlola ngokucophelela ukuthi ngabe ukwelashwa okufanele yini kuwe. Izimo ezithile zezokwelapha noma izimo zingenza lokhu kwelashwa kube yingozi kakhulu.

Akufanele wamukele i-ipilimumab uma wake waba nokusabela okukhulu komzimba okungalungile kuyo esikhathini esidlule noma uma unezifo ezithile ezizenzakalelayo ezingase zibe zimbi ngokwengeziwe ngokusebenzisa amasosha omzimba.

Udokotela wakho uzoba nokuqapha okukhulu mayelana nokunikeza i-ipilimumab uma unezimo ezinje:

\n
• Izifo ezizenzakalelayo ezisebenzayo njenge-rheumatoid arthritis noma i-lupus
\n
• Isifo samathumbu esivuvukalayo njengesifo sikaCrohn noma i-ulcerative colitis
\n
• Isifo sesibindi esibi noma i-hepatitis esebenzayo
\n
• Isifo samaphaphu esibi noma izinkinga zokuphefumula
\n
• Ukufakelwa kwesitho esisanda kwenziwa
\n
• Ukukhulelwa noma ukuncelisa ibele
\n

Ukuba nalezi zimo akukukhishi ngokuzenzakalelayo ekwelashweni, kodwa udokotela wakho uzodinga ukulinganisa izinzuzo ezingaba khona nezingozi ngokucophelela okukhulu.

Ubudala bodwa abuyona isizathu sokugwema i-ipilimumab, kodwa abadala bangase babe sengozini enkulu yemiphumela ethile emibi. Impilo yakho yonke nekhono lokubekezelela ukwelashwa kuyizici ezibaluleke kakhulu kuneminyaka yakho.

Igama Lomkhiqizo le-Ipilimumab

I-Ipilimumab ithengiswa ngaphansi kwegama lomkhiqizo elithi Yervoy. Leli yilo kuphela igama lomkhiqizo elitholakala ngalo umuthi e-United States.

I-Yervoy yenziwa yi-Bristol Myers Squibb futhi yayiyisithiyo sokuqala se-CTLA-4 esavunywa yi-FDA. Ithole imvume yayo yokuqala ngo-2011 yokwelapha i-melanoma ethuthukile.

Uma wamukela ukwelashwa kwakho, uzobona

Udktela wakho angase acabangele lezi ezinye izindlela uma i-ipilimumab ingakulungele noma uma umdlavuza wakho ungasabeli kuyo. Ngezikhathi ezithile, le mithi isetshenziswa ngokuhlangana ne-ipilimumab ukuze kutholakale imiphumela engcono nakakhulu.

Nazi ezinye izindlela eziyinhloko udktela wakho angase axoxe ngazo:

• Nivolumab (Opdivo) - ivimba i-PD-1 futhi ivame ukusetshenziswa ne-ipilimumab
• Pembrolizumab (Keytruda) - nayo ivimba i-PD-1 futhi ingase isetshenziswe yodwa
• Atezolizumab (Tecentriq) - ivimba iphrotheni ye-PD-L1
• Dostarlimab (Jemperli) - i-inhibitor ye-PD-1 entsha yezinye izinhlobo zomdlavuza

Ukukhetha phakathi kwale mithi kuncike ohlotsheni lomdlavuza wakho, izici zawo, nempilo yakho yonke. Udktela wakho we-oncologist uzosiza ekunqumeni ukuthi iyiphi inketho ekunikeza ithuba elingcono lokuphumelela.

Ingabe i-Ipilimumab Ingcono Kune-Nivolumab?

I-Ipilimumab ne-nivolumab zisebenza ngendlela ehlukile futhi zivame ukusebenza kahle uma zisetshenziswa ndawonye kunokuba ziqhathaniswe zodwa. Zombili ziyizidakamizwa ezinamandla ze-immunotherapy, kodwa ziqondise izingxenye ezihlukene zesimiso sakho somzimba sokuzivikela.

I-Nivolumab ivame ukubangela imiphumela emibi embalwa kuno-ipilimumab, kodwa i-ipilimumab ingase inikeze izimpendulo eziqhubekayo ezigulini ezithile. Ukuhlanganiswa kwazo zombili izidakamizwa kukhombise imiphumela engcono uma iqhathaniswa nesidakamizwa esisodwa emithonjeni eminingi yezokwelapha.

Udktela wakho uzocabangela izici eziningana lapho ekhetha phakathi kwale mithi, okuhlanganisa uhlobo lomdlavuza wakho, isigaba sawo, impilo yakho yonke, kanye nekhono lakho lokubekezelela imiphumela emibi. Akukho ngomuthi owodwa ongcono kunomunye - kuncike esimweni sakho.

Iziguli eziningi manje zithola zombili izidakamizwa ndawonye njengokwelashwa okuhlanganisiwe, okuye kwaba yindlela yokwelapha ejwayelekile yezinhlobo eziningana zomdlavuza othuthukile.

Imibuzo Evame Ukubuzwa Mayelana ne-Ipilimumab

Ingabe i-Ipilimumab iphephile kubantu abanezifo ze-Autoimmune?

Ipilimumab idinga ukuqapha okwengeziwe uma unesifo esizimele ngoba singenza lezi zimo zibe zimbi kakhulu. Udokotela wakho uzoqapha ngokucophelela ukuthi ngabe izinzuzo zidlula izingozi esimweni sakho esithile.

Ezinye iziguli ezinokulawulwa kahle kwezifo ezizimele ziye zamukela ngempumelelo i-ipilimumab, kodwa zidinga ukuqapha okuseduze kakhulu futhi zingadinga eminye imithi ukuphatha ukuqubuka kwesimo sazo esizimele.

Kufanele ngenzeni uma ngiphuthelwa ngengozi umthamo we-Ipilimumab?

Njengoba i-ipilimumab inikezwa endaweni yezokwelapha, ukuphuthelwa umthamo kuvame ukwenzeka ngenxa yezingxabano zokuhlela noma izizathu zezokwelapha. Xhumana nethimba lakho le-oncology ngokushesha ukuze uhlele kabusha i-aphoyintimenti yakho.

Udokotela wakho uzoqaphela indlela engcono kakhulu yokuqhubeka nohlelo lwakho lokwelashwa. Ezimweni eziningi, uzothola umthamo ophuthelwe ngokushesha okukhulu, futhi imithamo eseleyo izolungiswa ngokufanele ukuze kugcinwe isikhathi esifanele phakathi kokwelashwa.

Kufanele ngenzeni uma ngiba nokusabela okukhulu ku-Ipilimumab?

Uma uba nohudo olukhulu, ubunzima bokuphefumula, ukusabela okukhulu kwesikhumba, noma yiziphi ezinye izimpawu ezikhathazayo ngemuva kokuthola i-ipilimumab, xhumana nethimba lakho lezempilo ngokushesha noma uye egumbini eliphuthumayo.

Ungalindi ukubona ukuthi izimpawu ziyathuthuka yini zodwa. Ukwelashwa kwangaphambi kwesikhathi kwemiphumela emibi emibi kubalulekile futhi kungavimbela izinkinga ezingathi sína. Ithimba lakho lezokwelapha linemithetho ethile yokuphatha imiphumela emibi ye-immunotherapy.

Ngingayeka nini ukuthatha i-Ipilimumab?

Ukwelashwa okujwayelekile kwe-ipilimumab kuqukethe imithamo emine kuphela enikezwa ngaphezu kwamasonto angu-12, ngakho-ke iziguli eziningi ziqeda ngokwemvelo inkambo yazo yokwelashwa. Udokotela wakho uzoqaphela ukuthi ngabe udinga ukuyeka ngaphambi kwesikhathi ngenxa yemiphumela emibi noma ngabe imithamo eyengeziwe ingaba usizo.

Noma ngemva kokuqeda ukwelashwa, udokotela wakho uzoqhubeka nokukuqapha kokubili ukusabela ekwelashweni kanye nemiphumela emibi ezinqenayo. Umuthi ungaqhubeka usebenza emzimbeni wakho izinyanga ngemva komthamo wakho wokugcina.

Ngingathatha Eminye Imithi Ngesikhathi Ngithola Ipilimumab?

Ungathatha imithi eminingi ngenkathi uthola i-ipilimumab, kodwa eminye ingase ihlangane nokwelashwa noma ithinte amasosha akho omzimba. Njalo yazisa ithimba lakho lezempilo ngayo yonke imithi, izithasiselo, kanye nemikhiqizo yezitshalo oyithathayo.

Udokotela wakho kungadingeka ukuthi alungise imithi ethile, ikakhulukazi lezo ezithinta amasosha akho omzimba njengama-steroid noma ama-immunosuppressants. Ungayeki noma uqale imithi emisha ngaphandle kokuxoxa ngayo neqembu lakho le-oncology kuqala.